402
Participants
Start Date
August 3, 2017
Primary Completion Date
May 23, 2028
Study Completion Date
July 18, 2028
Vedolizumab IV
Vedolizumab IV infusion
Placebo
Matching-placebo IV infusion
RECRUITING
Gastroenterology, Taiyuan
COMPLETED
Gastroenterology, Beijing
RECRUITING
Gastroenterology, Beijing
RECRUITING
Gastroenterology, Shenyang
COMPLETED
Gastroenterology, Changchun
RECRUITING
Gastroenterology, Shanghai
RECRUITING
Gastroenterology, Shanghai
COMPLETED
Gastroenterology, Shanghai
COMPLETED
Gastroenterology, Shanghai
RECRUITING
Gastroenterology, Nanjing
RECRUITING
Gastroenterology, Nanjing
RECRUITING
Gastroenterology, Hefei
RECRUITING
Gastroenterology, Wuxi
RECRUITING
Gastroenterology, Hangzhou
RECRUITING
Gastroenterology, Hangzhou
RECRUITING
Gastroenterology, Nanchang
COMPLETED
Gastroenterology, Fuzhou
RECRUITING
Gastroenterology, Xiamen
COMPLETED
Gastroenterology, Zhangzhou
COMPLETED
Gastroenterology, Chongqing
RECRUITING
Gastroenterology, Chongqing
RECRUITING
Gastroenterology, Changsha
RECRUITING
Gastroenterology, Changsha
COMPLETED
Gastroenterology, Changsha
COMPLETED
Gastroenterology, Wuhan
RECRUITING
Gastroenterology, Wuhan
RECRUITING
Gastroenterology, Wuhan
RECRUITING
Gastroenterology, Zhengzhou
RECRUITING
Gastroenterology, Guangzhou
RECRUITING
Gastroenterology, Guangzhou
RECRUITING
Gastroenterology, Guangzhou
RECRUITING
Gastroenterology, Guangzhou
RECRUITING
Gastroenterology, Meizhou
COMPLETED
Gastroenterology, Shantou
COMPLETED
Gastroenterology, Chengdu
COMPLETED
Gastroenterology, Kunming
RECRUITING
Gastroenterology, Xi’an
RECRUITING
Gastroenterology, Yinchuan
RECRUITING
Gastroenterology, Shijiazhuang
Lead Sponsor
Takeda
INDUSTRY